Pharma Deals Review, Vol 2008, No 97 (2008)

Font Size:  Small  Medium  Large

Daiichi Sankyo Diversifies into Generics through Major Investment in Indian Giant

Sally Mardikian PhD

Abstract


Several overseas acquisitions by Japanese companies have taken place over the last few months, with Daiichi Sankyo being the latest company taking steps to do so. Its venture, however, is a lot closer to home.

Full Text: pdf html

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.